Program Description

Miss the live event? Watch the video archive now »

Anticoagulation: New Drugs, New Therapies took place on Wednesday, December 7, 2011 and featured leading experts in the field discussing the recent advances in anticoagulation as well as its role in the treatment of patients with atrial fibrillation. Focus was given primarily to recent clinical trials and their outcomes.

The live 1.5 hour webinar was moderated by Dr. Gregory Michaud and consisted of dynamic didactic presentations from expert physicians, Drs. Michael Ezekowitz and Elaine Hylek,  followed by an engaging panel discussion and audience Q&A session.

Faculty

• Gregory Michaud, MD, FHRS
  Brigham & Women's Hospital, Boston, MA
• Elaine Hylek, MD, MPH
  Boston University School of Medicine, Boston, MA
• Michael Ezekowitz, MBChB, Dphil, MA
  The Lankenau Institute for Medical Research, Wynnewood, PA

 Target Audience

The intended audience for this program includes:

• Electrophysiologist physicians and fellows
• Electrophysiologist nurses, technicians, physician assistants
• Cardiology physicians and fellows
• Cardiology nurses, technicians, physician assistants

Learning Objectives

Upon completion of this activity, participants will be able to:

• Discuss recent clinical trials related to anticoagulation
• Describe recent clinical trial results and discoveries related to anticoagulation
• Explain how new anticoagulants play a role in the treatment of AF

Disclosure Policy

It is the policy of the Heart Rhythm Society and American College of Cardiology to ensure balance, independent objectivity, and scientific rigor in all its supported educational programs. All faculty members participating in educational activities are required to disclose to the program audience any real of apparent conflicts of interest held within the past 12 months. The Heart Rhythm Society and American College of Cardiology implement a mechanism to identify and resolve all conflicts of interest prior to delivering the educational activity to learners.

Disclaimer

The Anticoagulation: New Drugs, New Therapies webinar provides a forum for the open exchange and discussion of research results and scientific advancements in the field of cardiovascular pacing and electrophysiology; however, the Heart Rhythm Society or American College of Cardiology makes no representation or warranty as to the truth, originality, or accuracy of the information presented in this activity. Nor are the views expressed by the individual speakers necessarily the views of the Society or the College. The Heart Rhythm Society and American College of Cardiology support the ACCME's policy on evidence-based content and encourages faculty to adhere to these standards when planning a presentation.

www.AFibprofessional.org is supported by a grant from sanofi aventis and Boehringer Ingelheim.